講演情報

[O15-05]DMDにおけるdelandistrogene moxeparvovecの長期安全性及び忍容性:第I相~第III相臨床試験のプール解析

石垣 景子1, Crystal Proud2, Craig M. McDonald3, Eugenio M. Mercuri4, Francesco Muntoni5, Craig M. Zaidman6, Sachi Dharia7, Stefanie Mason7, Jianfeng Meng7, Alexander P. Murphy8, Emanuel Palatinsky7, Carol Reid8, Christoph Wandel9, Jerry R. Mendell7 (1.東京女子医科大学医学部小児科, 2.Children's Hospital of The King's Daughters, Norfolk, VA, USA, 3.UC Davis, Davis, CA, USA, 4.Pediatric Neurology Institute, Catholic University and Nemo Pediatrico, Fondazione Policlinico Gemelli IRCCS, Rome, Italy, 5.The Dubowitz Neuromuscular Centre, Great Ormond Street Institute of Child Health University College London, London, UK, 6.Washington University in Saint Louis, Saint Louis, MO, USA, 7.Sarepta Therapeutics, Inc., Cambridge, MA, USA, 8.Roche Products Ltd, Welwyn Garden City, UK, 9.F. Hoffmann-La Roche Ltd, Basel, Switzerland)

閲覧にはパスワードが必要です

抄録パスワード認証
パスワードは、「第67回日本小児神経学会学術集会プログラム・抄録集」(「脳と発達」第57巻学術集会号)に記載してあります。